{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:33:59Z","timestamp":1791408839951,"version":"4.3.3"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015756","name":"Cilag","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015756","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008723","name":"Suomen L\u00e4\u00e4ketieteen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003125","name":"Suomen Kulttuurirahasto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["345326"],"award-info":[{"award-number":["345326"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["315969"],"award-info":[{"award-number":["315969"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["320107"],"award-info":[{"award-number":["320107"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jad.2022.06.040","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T02:31:20Z","timestamp":1655951480000},"page":"43-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Allopurinol, dipyridamole and calcium channel blockers in the treatment of bipolar disorder \u2013 A nationwide cohort study"],"prefix":"10.1016","volume":"313","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5627-2388","authenticated-orcid":false,"given":"Jonne","family":"Lintunen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markku","family":"L\u00e4hteenvuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Tanskanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jari","family":"Tiihonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Taipale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5 Pt 1","key":"10.1016\/j.jad.2022.06.040_bb0005","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1399-5618.2006.00363.x","article-title":"Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial","volume":"8","author":"Akhondzadeh","year":"2006","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2022.06.040_bb0010","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"issue":"3","key":"10.1016\/j.jad.2022.06.040_bb0015","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3390\/brainsci10030160","article-title":"Purinergic signaling and related biomarkers in depression","volume":"10","author":"Bartoli","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.jad.2022.06.040_bb0020","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jpsychires.2021.09.018","article-title":"Repurposed drugs as adjunctive treatments for mania and bipolar depression: a meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials","volume":"143","author":"Bartoli","year":"2021","journal-title":"J. Psychiatry Res."},{"issue":"1","key":"10.1016\/j.jad.2022.06.040_bb0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1192\/bjp.bp.115.180281","article-title":"Allopurinol as add-on treatment for mania symptoms in bipolar disorder: systematic review and meta-analysis of randomised controlled trials","volume":"210","author":"Bartoli","year":"2017","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2022.06.040_bb0030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jpsychires.2016.07.007","article-title":"Uric acid levels in subjects with bipolar disorder: a comparative meta-analysis","volume":"81","author":"Bartoli","year":"2016","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2022.06.040_bb0035","doi-asserted-by":"crossref","DOI":"10.1152\/physrev.00043.2006","article-title":"Physiology and pathophysiology of purinergic neurotransmission","author":"Burnstock","year":"2007","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.jad.2022.06.040_bb0040","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/mp.2017.188","article-title":"Purinergic system in psychiatric diseases","volume":"23","author":"Cheffer","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2022.06.040_bb0045","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jad.2017.09.034","article-title":"Allopurinol augmentation in acute mania: a meta-analysis of placebo-controlled trials","volume":"226","author":"Chen","year":"2018","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.jad.2022.06.040_bb0050","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.22466","article-title":"Prevalence of the metabolic syndrome in patients with gout: the third National Health and nutrition examination survey","volume":"57","author":"Choi","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.jad.2022.06.040_bb0055","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/mp.2016.86","article-title":"A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development","volume":"21","author":"Cipriani","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2022.06.040_bb0060","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1399-5618.2012.01001.x","article-title":"Allopurinol augmentation in the outpatient treatment of bipolar mania: a pilot study","volume":"14","author":"Fan","year":"2012","journal-title":"Bipolar Disord."},{"issue":"10","key":"10.1016\/j.jad.2022.06.040_bb0065","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1161\/01.STR.0000179044.37760.9d","article-title":"Role of adenosine and nitric oxide on the mechanisms of action of dipyridamole","volume":"36","author":"Gamboa","year":"2005","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.jad.2022.06.040_bb0070","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.mp.4001793","article-title":"Treatment-resistant bipolar disorder","volume":"11","author":"Gitlin","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2022.06.040_bb0075","article-title":"Cellular calcium in bipolar disorder: systematic review and meta-analysis","author":"Harrison","year":"2019","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2022.06.040_bb0080","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/jamapsychiatry.2018.3907","article-title":"Association of hydroxylmethyl glutaryl coenzyme a reductase inhibitors, L-type calcium channel antagonists, and biguanides with rates of psychiatric hospitalization and self-harm in individuals with serious mental illness","volume":"76","author":"Hayes","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2022.06.040_bb0085","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pneurobio.2015.09.002","article-title":"Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders","volume":"134","author":"Heyes","year":"2015","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.jad.2022.06.040_bb0090","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.schres.2013.06.038","article-title":"Adenosine hypothesis in schizophrenia and bipolar disorder: a systematic review and meta-analysis of randomized controlled trial of adjuvant purinergic modulators","volume":"149","author":"Hirota","year":"2013","journal-title":"Schizophr. Res."},{"issue":"8","key":"10.1016\/j.jad.2022.06.040_bb0095","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.euroneuro.2014.05.013","article-title":"In a double-blind, randomized and placebo-controlled trial, adjuvant allopurinol improved symptoms of mania in in-patients suffering from bipolar disorder","volume":"24","author":"Jahangard","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.jad.2022.06.040_bb0100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1192\/bjp.bp.114.159806","article-title":"CACNA1C polymorphism and altered phosphorylation of tau in bipolar disorder","volume":"208","author":"Jakobsson","year":"2016","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2022.06.040_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eurpsy.2016.04.007","article-title":"Anxiety symptoms in a major mood and schizophrenia spectrum disorders","volume":"37","author":"Karpov","year":"2016","journal-title":"European Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2022.06.040_bb0110","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/bdi.12772","article-title":"New drug candidates for bipolar disorder\u2014a nation-wide population-based study","volume":"21","author":"Kessing","year":"2019","journal-title":"Bipolar Disord."},{"issue":"21","key":"10.1016\/j.jad.2022.06.040_bb0115","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa1203241","article-title":"Medication for attention deficit-hyperactivity disorder and criminality","volume":"367","author":"Lichtenstein","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jad.2022.06.040_bb0120","doi-asserted-by":"crossref","DOI":"10.1038\/s41537-020-00135-y","article-title":"Adenosine modulators and calcium channel blockers as add-on treatment for schizophrenia","volume":"7","author":"Lintunen","year":"2021","journal-title":"NPJ Schizophr."},{"issue":"3","key":"10.1016\/j.jad.2022.06.040_bb0125","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/EDE.0b013e3181d61eeb","article-title":"Negative controls: a tool for detecting confounding and bias in observational studies","volume":"21","author":"Lipsitch","year":"2010","journal-title":"Epidemiology"},{"issue":"8","key":"10.1016\/j.jad.2022.06.040_bb0130","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.4088\/JCP.v69n0806","article-title":"A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania","volume":"69","author":"Machado-Vieira","year":"2008","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2022.06.040_bb0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.jad.2022.06.040_bb0140","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/s41588-019-0397-8","article-title":"Genome-wide association study identifies 30 loci associated with bipolar disorder","volume":"51","author":"Stahl","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jad.2022.06.040_bb0145","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2147\/CLEP.S116160","article-title":"Agreement between PRE2DUP register data modeling method and comprehensive drug use interview among older persons","volume":"8","author":"Taipale","year":"2016","journal-title":"Clin. Epidemiol."},{"issue":"21","key":"10.1016\/j.jad.2022.06.040_bb0150","first-page":"1","article-title":"From prescription drug purchases to drug use periods \u2013 a second generation method (PRE2DUP)","volume":"15","author":"Tanskanen","year":"2015","journal-title":"BMC Med. Inform. Decis. Mak."},{"issue":"1","key":"10.1016\/j.jad.2022.06.040_bb0155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jnc.14841","article-title":"The role of adenosine receptors in mood and anxiety disorders","volume":"151","author":"van Calker","year":"2019","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.jad.2022.06.040_bb0160","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/bdi.12202","article-title":"Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and\/or antipsychotic agents in manic patients with bipolar disorder","volume":"16","author":"Weiser","year":"2014","journal-title":"Bipolar Disord."},{"issue":"Suppl. 13","key":"10.1016\/j.jad.2022.06.040_bb0165","first-page":"38","article-title":"The economic burden of bipolar disease","volume":"61","author":"Woods","year":"2000","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2022.06.040_bb0170","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/mp.2014.143","article-title":"Functional implications of a psychiatric risk variant within CACNA1C in induced human neurons","volume":"20","author":"Yoshimizu","year":"2015","journal-title":"Mol. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032722007005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032722007005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:20:47Z","timestamp":1777494047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032722007005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":34,"alternative-id":["S0165032722007005"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2022.06.040","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allopurinol, dipyridamole and calcium channel blockers in the treatment of bipolar disorder \u2013 A nationwide cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2022.06.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}